1770 related articles for article (PubMed ID: 18416436)
1. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
2. Focused proteomics in post-mortem human spinal cord.
Ekegren T; Hanrieder J; Aquilonius SM; Bergquist J
J Proteome Res; 2006 Sep; 5(9):2364-71. PubMed ID: 16944948
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential CSF biomarkers in ALS.
Pasinetti GM; Ungar LH; Lange DJ; Yemul S; Deng H; Yuan X; Brown RH; Cudkowicz ME; Newhall K; Peskind E; Marcus S; Ho L
Neurology; 2006 Apr; 66(8):1218-22. PubMed ID: 16481598
[TBL] [Abstract][Full Text] [Related]
4. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
5. The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences.
Becker JS; Jakubowski N
Chem Soc Rev; 2009 Jul; 38(7):1969-83. PubMed ID: 19551177
[TBL] [Abstract][Full Text] [Related]
6. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
7. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
Oh JH; Pan S; Zhang J; Gao J
Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
[TBL] [Abstract][Full Text] [Related]
8. Making broad proteome protein measurements in 1-5 min using high-speed RPLC separations and high-accuracy mass measurements.
Shen Y; Strittmatter EF; Zhang R; Metz TO; Moore RJ; Li F; Udseth HR; Smith RD; Unger KK; Kumar D; Lubda D
Anal Chem; 2005 Dec; 77(23):7763-73. PubMed ID: 16316187
[TBL] [Abstract][Full Text] [Related]
9. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
10. Comparison of indirect and direct approaches using ion-trap and Fourier transform ion cyclotron resonance mass spectrometry for exploring viperid venom proteomes.
Fox JW; Ma L; Nelson K; Sherman NE; Serrano SM
Toxicon; 2006 May; 47(6):700-14. PubMed ID: 16574175
[TBL] [Abstract][Full Text] [Related]
11. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
Novikova SI; He F; Cutrufello NJ; Lidow MS
Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
[TBL] [Abstract][Full Text] [Related]
12. The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).
Rosenling T; Slim CL; Christin C; Coulier L; Shi S; Stoop MP; Bosman J; Suits F; Horvatovich PL; Stockhofe-Zurwieden N; Vreeken R; Hankemeier T; van Gool AJ; Luider TM; Bischoff R
J Proteome Res; 2009 Dec; 8(12):5511-22. PubMed ID: 19845411
[TBL] [Abstract][Full Text] [Related]
13. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
Leung SM; Pitts RL
Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
[TBL] [Abstract][Full Text] [Related]
14. Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery.
Krüger T; Lautenschläger J; Grosskreutz J; Rhode H
Proteomics Clin Appl; 2013 Jan; 7(1-2):123-35. PubMed ID: 23129563
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of plasma from Portuguese patients with familial amyotrophic lateral sclerosis.
Palma AS; De Carvalho M; Grammel N; Pinto S; Barata N; Conradt HS; Costa J
Amyotroph Lateral Scler; 2008 Dec; 9(6):339-49. PubMed ID: 18608108
[TBL] [Abstract][Full Text] [Related]
16. Application of LC/MS to proteomics studies: current status and future prospects.
Chen G; Pramanik BN
Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
[TBL] [Abstract][Full Text] [Related]
17. Proteome analysis of Escherichia coli using high-performance liquid chromatography and Fourier transform ion cyclotron resonance mass spectrometry.
Ihling C; Sinz A
Proteomics; 2005 May; 5(8):2029-42. PubMed ID: 15852340
[TBL] [Abstract][Full Text] [Related]
18. A review of current applications of mass spectrometry for neuroproteomics in epilepsy.
Liu X; Wen F; Yang J; Chen L; Wei YQ
Mass Spectrom Rev; 2010; 29(2):197-246. PubMed ID: 19598206
[TBL] [Abstract][Full Text] [Related]
19. The application of proteomic techniques to fungal protein identification and quantification.
Rohrbough JG; Galgiani JN; Wysocki VH
Ann N Y Acad Sci; 2007 Sep; 1111():133-46. PubMed ID: 17344531
[TBL] [Abstract][Full Text] [Related]
20. Miniaturized proteomics and peptidomics using capillary liquid separation and high resolution mass spectrometry.
Ramström M; Bergquist J
FEBS Lett; 2004 Jun; 567(1):92-5. PubMed ID: 15165899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
